Today's Information

Provided by: Bora Pharmaceuticals Co., LTD.
SEQ_NO 2 Date of announcement 2022/01/21 Time of announcement 19:46:04
Subject
 The Company's board of director ractify the
Company's 2021 First Employee Stock Option Plan
Date of events 2022/01/21 To which item it meets paragraph 11
Statement
1.Date of occurrence of the event:2022/01/21
2.Date of the original announcement and reporting:2021/11/11
3.Summary of the content originally announced and reported:
The Company's board of director approve and publish the
Company's 2021 First Employee Stock Option Plan 2022/11/11,
below are the excerpt of article 3 and article 7
Article 3 eligibility criteria for optionees
(2)Number of Options to be granted to employees are decided
after taking into consideration factors such as title, job
performance, seniority, past and expect overall contribution
or special achievements. After Chairman��s approval, below
procedure will be followed:
i. If the Optionee serve as the director or employee
concurrently serve as board member of the Company, the
Optionee shall obtain the prior approval from the Compensation
Committee of the Company, then submit to the Board for
approval. Employee from controlling or subordinate company
who also serve as the director or board member of the Company
will follow the aforementioned procedure, obtain the prior
approval from the Compensation Committee of the Company, then
submit to the Board for approval.
ii. The Company��s controlling or subordinate company��s
employee that does not fall into above criteria shall obtain
the prior approval from the Audit Committee of the Company,
then submit to the Board for approval.
Article 7 adjustment of subscription price
(1)After the Options are granted, except for (a) new common
shares derived from the company��s securities issued with
conversion or subscription rights or (b) new common shares
issued for compensating employees, if there is an increase
to the number of the issued Shares (including private
placement, cash capital increase, capitalization of retained
earning, capitalization of capital reserve, merger, spin off,
stock split, new shares in connection with receiving transfer
of shares of another company and cash capital increase for
overseas depository receipt), the exercise price of each Option
shall be subject to adjustment in accordance with the
following formula.
Adjusted exercise price = Exercise price prior to adjustment
* [total number of issued shares + (offering price per share
* total number of newly issued shares) �� market price per
common share] �� (total number of issued shares + total number
of newly issued shares)
4.Reason for change and its main content:
To follow the local regulation's request to revise the
Company's 2021 First Employee Stock Option Plan, the Company's
board of director ractify the 2021 First Employee Stock Option
Plan on 2022/01/21, below are the revised excerpt of article 3
and article 7
Article 3 eligibility criteria for optionees
(2)Number of Options to be granted to employees are decided
after taking into consideration factors such as title, job
performance, seniority, past and expect overall contribution
or special achievements. The evaluation criteria is listed
as follows:
i.The annual performance review is above the average.
ii. Due to the excellent performance of the project work, or
a significant contribution to the company.
iii. Reported by the department manager that it is beneficial
to the company's growth.
iv. Possess special job skills required by the company.
v. Outstanding employees of the year.
(3)After Chairman��s approval of employee list and number of
options to be granted, below procedure will be followed:
i. If the Optionee serve as the director or employee concurrently
serve as board member of the Company, the Optionee shall obtain
the prior approval from the Compensation Committee of the
Company, then submit to the Board for approval. Employee from
controlling or subordinate company who also serve as the
director or board member of the Company will follow the
aforementioned procedure, obtain the prior approval from the
Compensation Committee of the Company, then submit to the Board
for approval.
ii. The Company��s controlling or subordinate company��s
employee that does not fall into above criteria shall obtain
the prior approval from the Audit Committee of the Company,
then submit to the Board for approval.
Article 7 adjustment of subscription price
(1)After the Options are granted, except for (a) new common
shares derived from the company��s securities issued with
conversion or subscription rights or (b) new common shares
issued for compensating employees, if there is an increase to
the number of the issued Shares (including private placement,
cash capital increase, capitalization of retained earning,
capitalization of capital reserve, merger, spin off, stock
split, new shares in connection with receiving transfer of
shares of another company and cash capital increase for overseas
depository receipt), the exercise price of each Option shall
be subject to adjustment in accordance with the following
formula. When the face value of the stock is changed and cause
the increase in common shares, the base date for adjustment is
when new share is issued. The adjustment will be made on the
actual payment date, if there is any.
Adjusted exercise price = Exercise price prior to adjustment
* [total number of issued shares + (offering price per share
* total number of newly issued shares) �� market price per
common share] �� (total number of issued shares + total number
of newly issued shares)
When face value of the stock is changed:
Adjusted exercise price = Exercise price prior to adjustment
* [total number of issued shares before the change in stock
face value�� total number of issued shares after the change
in stock face value]
(2)After the Options are granted, the exercise price of each
Option shall be subject to adjustment on the date of capital
reduction in accordance with the following formula (the
adjusted exercise price shall be rounded up to the nearest
tenth of one New Taiwan Dollar) in the case of the Company��s
capital reduction is not caused by the cancellation of the
treasure shares of the Company. When the face value of the
stock is changed and cause the increase in common shares,
the base date for adjustment is when new share is issued.
Reduce capital to offset losses:
Adjusted exercise price = Exercise price prior to adjustment
�� (total number of issued common shares before capital
reduction �� total number of issued common shares after
capital reduction)
Capital reduction in cash:
Adjusted exercise price = (Exercise price prior to adjustment
�V cash refund per share) * (total number of issued common
shares before capital reduction �� total number of issued
common shares after capital reduction)
When face value of the stock is changed:
Adjusted exercise price = Exercise price prior to adjustment
* [total number of issued shares before the change in stock
face value�� total number of issued shares after the change
in stock face value]
5.Impact on the Company's finance and business after the change:NA
6.Any other matters that need to be specified:NA

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Bora Pharmaceuticals Co. Ltd. published this content on 21 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 January 2022 12:02:06 UTC.